| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_362a44b9d9eddf88667c89f3a671d059 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39541
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 |
| filingDate |
2018-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_989f5e04ded9d1199571c4dd2123fd67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a652745b89623d17fcce7d6447eef02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd24736119bbc0bfcdb712cd38b860a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2696a3b25eecb8387aafcebb8272ad6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb90d83ba87a95f2260e9cbb07305509
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ec8abaaf875d5b889507d7fbe0babe4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd5603aeb52c3a593e714a18d829e816 |
| publicationDate |
2019-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2018205231-A1 |
| titleOfInvention |
Isoform-specific, context-permissive TGFβ1 inhibitors and use thereof |
| abstract |
Disclosed herein are therapeutic use of isoform-specific, context-permissive inhibitors of TGFβ1 in the treatment of disease that involve TGFβ1 dysregulation. |
| priorityDate |
2017-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |